Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.85 CAD | +0.36% |
|
-3.21% | +4.84% |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 9.34 for the current year.
- The company is one of the best yield companies with high dividend expectations.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.84% | 26.66B | - | ||
+4.92% | 72.04B | B- | ||
+7.14% | 49.68B | B+ | ||
+20.29% | 45.8B | B+ | ||
+12.85% | 41.53B | B+ | ||
+22.11% | 38.29B | B | ||
+19.76% | 34.2B | B | ||
-4.03% | 27.87B | B | ||
+31.37% | 26.7B | A | ||
-19.70% | 24.42B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- GWO Stock
- GWO.PR.N Stock
- Ratings Great-West Lifeco Inc.